Incidence of pathologic complete response in women treated with preoperative chemotherapy for locally advanced breast cancer: correlation of histology, hormone receptor status, Her2/Neu, and gross pathologic findings
Tóm tắt
Từ khóa
Tài liệu tham khảo
Pusztai, 2008, Preoperative systemic chemotherapy and pathologic assessment of response, Pathol Oncol Res, 14, 169, 10.1007/s12253-008-9070-8
Cleator, 2002, The biology of neoadjuvant chemotherapy for breast cancer, Endocr Relat Cancer, 9, 183, 10.1677/erc.0.0090183
Bonaddona, 1992, Evolving concepts in the systemic adjuvant treatment of breast cancer, Cancer Res, 52, 2127
Fisher, 1989, Presence of a growth-stimulating factor in serum following primary tumor removal in mice, Cancer Res, 49, 1996
Newman, 2003, Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcome, Ann Surg Oncol, 10, 734, 10.1245/ASO.2003.03.081
Gonzalez-Angulo, 2005, Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy, J Clin Oncol, 23, 7098, 10.1200/JCO.2005.11.124
Bonadonna, 1990, Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more, J Natl Cancer Inst, 82, 1539, 10.1093/jnci/82.19.1539
Fisher, 1997, Effect of preoperative chemotherapy in local-regional disease in women with operable breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-18, J Clin Oncol, 15, 2483, 10.1200/JCO.1997.15.7.2483
Jacquillat, 1986, Neoadjuvant chemotherapy in the conservative management of breast cancers: study of 143 patients, Recent Results Cancer Res, 103, 113, 10.1007/978-3-642-82671-9_12
Kuerer, 1999, Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy, J Clin Oncol, 17, 460, 10.1200/JCO.1999.17.2.460
Jones, 2006, Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma, Br J Cancer, 94, 358, 10.1038/sj.bjc.6602950
Chevallier, 1993, Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate, Am J Clin Oncol, 16, 223, 10.1097/00000421-199306000-00006
Portera, 2007, Neoadjuvant chemotherapy: a step closer to individualized therapy, 51
Rajan, 2004, Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response, Cancer, 100, 1365, 10.1002/cncr.20134
Fisher, 2002, Pathobiology of preoperative chemotherapy. Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) Protocol B-18, Cancer, 95, 681, 10.1002/cncr.10741
Apple, 2006, How do we measure a residual tumor size in histopathology (the gold standard) after neoadjuvant chemotherapy?, Breast, 15, 370, 10.1016/j.breast.2005.08.002
Kaufmann, 2005, Preoperative (neoadjuvant) systemic treatment of breast cancer, Breast, 14, 576, 10.1016/j.breast.2005.08.010
Cristofanilli, 2005, Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes, J Clin Oncol, 23, 41, 10.1200/JCO.2005.03.111
Colleoni, 2000, Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors, Ann Oncol, 11, 1057, 10.1023/A:1008334404825
Buzdar, 2003, Pathologic complete response to chemotherapy is related with hormone receptor status, Breast Cancer Res Treat, 82, S69a
Teixeira, 1995, Estrogen promotes chemotherapeutic drug resistance by mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells, Cancer Res, 55, 3902
Rasbridge, 1994, The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma, Br J Cancer, 70, 335, 10.1038/bjc.1994.303
Feldman, 1986, Pathological assessment of response to induction chemotherapy in breast cancer, Cancer Res, 46, 2578
Morrow, 1986, Multimodal therapy for locally advanced breast cancer, Arch Surg, 121, 1291, 10.1001/archsurg.1986.01400110081014
Newman, 2002, A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast conservation therapy feasibility, Ann Surg Oncol, 9, 228, 10.1007/BF02573059
Singh, 2005, Expression of vascular endothelial growth factor and proliferation marker MiB1 are influenced by neoadjuvant chemotherapy in locally advanced breast cancer, Appl Immunohistochem Mol Morphol, 13, 147, 10.1097/01.pai.0000137364.36091.b0
Klauber-DeMore, 2006, Size of residual lymph node metastasis after neoadjuvant chemotherapy in locally advanced breast cancer patients is prognostic, Ann Surg Oncol, 13, 685, 10.1245/ASO.2006.03.010
Lenert, 1999, Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients, Ann Surg Oncol, 6, 762, 10.1007/s10434-999-0762-4